Latest News

Iktos Engine: APIs for Agentic workflows and Computational Chemistry Pipelines

Iktos Engine: APIs for Agentic workflows and Computational Chemistry Pipelines

Iktos announces it's new portfolio of APIs for R&D

Press releases and recognitions

Iktos Engine: APIs for Agentic workflows and Computational Chemistry Pipelines
05.21.2026

Iktos Engine: APIs for Agentic workflows and Computational Chemistry Pipelines

Chemspeed announcement image
03.26.2026

Iktos announces a new partnership with Chemspeed to help pharmaceutical companies unlock new possibilities in automated chemical research

Pierre Fabre Laboratories and Iktos announce Integrated Drug Discovery Collaboration
01.09.2026

Pierre Fabre Laboratories and Iktos announce Integrated Drug Discovery Collaboration

Press articles

Iktos featured by AWS Pioneers Project: Stories behind Europe's innovative breakthroughs

Iktos featured by AWS Pioneers Project: Stories behind Europe's innovative breakthroughs

Across Europe, innovators are reinventing what technology can do—for people and for the planet. From mapping the ocean to understanding how the human body works, these pioneers use cloud infrastructure, AI agents, and generative AI from AWS to solve humanity's toughest challenges, impacting millions of lives and protecting vital ecosystems.

Founded in 2016, Iktos is one of a handful of firms that saw the early potential of AI in drug discovery.
“It was kind of a revolution in our minds, saying that maybe you can use AI to optimise molecules,” explains Nicolas Do Huu, co-founder and CTO of Iktos.

Iktos featured by AWS Pioneers Project: Stories behind Europe's innovative breakthroughs
AWS Pioneers Project | 04.14.2026

Iktos featured by AWS Pioneers Project: Stories behind Europe's innovative breakthroughs

Drug discovery’s weakest link? Why synthesis is the critical bottleneck in the age of AI
Innovations in Pharmaceutical Technology | 12.16.2025

Drug discovery’s weakest link? Why synthesis is the critical bottleneck in the age of AI

Drug Target Review: Chemistry-aware AI offers new routes in small molecule design
Drug Target Review | 10.15.2025

Drug Target Review: Chemistry-aware AI offers new routes in small molecule design

Press Contact

PR Agency

PR Agency

For any communication need please contact PRLab
Mail :  dwain@prlab.co
Tel. : +31 202 443 748